Clinical Trials

Other hematologic neoplasm

33 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT05673967 2025-04-25

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

62 enrolled

Multiple Myeloma, Recurrence

NCT03288974 2025-04-15

Pomalyst PMS

397 enrolled

Multiple Myeloma, Recurrence

NCT04036448 2025-03-11

RevlimidPMS

28 enrolled

LymphoidMyeloid

Lymphoma, Follicular, Myelodysplastic Syndromes, Recurrence, Lymphoma, Mantle-Cell

NCT03647124 2025-03-04

A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma

105 enrolled

Recurrence, Lymphoma, Mantle-Cell

NCT05874921 2025-02-28

uTRACT

Recruiting

400 enrolled

Genitourinary

Carcinoma, Carcinoma, Transitional Cell, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Neoplasms

NCT06825845 2025-02-13

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

Not yet recruiting

1,500 enrolled

Multiple Myeloma, Recurrence

NCT03760952 2025-02-04

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

242 enrolled

Neoplasm Metastasis, Neoplasms, Recurrence

NCT05597085 2025-02-04

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

LymphoidOther hematologic neoplasm

32 enrolled 31 charts

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05324436 2025-01-20

A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)

Other solid neoplasmThoracic

75 enrolled

Mesothelioma, Malignant, Recurrence

NCT05217914 2024-10-24

A Study to Learn More About Copanlisib Treatment Patterns in People With Indolent Non-Hodgkin Lymphoma, a Type of Cancer That Grows and Spread Slowly and Develops in the Lymphatic System (a Part of Immune System) in Taiwan Under Real-word Conditions

6 enrolled

Recurrence

NCT06564363 2024-08-21

The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma

148 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Recurrence

NCT05645744 2024-07-22

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

LymphoidMyeloidOther hematologic neoplasm

3 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Leukemia, Hairy Cell, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT03742921 2023-12-06

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

150 enrolled

Recurrence, Lymphoma, T-Cell, Peripheral

NCT04198415 2023-10-19

VENCLL regPMOS

LymphoidOther hematologic neoplasm

4 enrolled

Neoplasms, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT05338892 2023-10-19

ORCHID

LymphoidOther hematologic neoplasm

595 enrolled

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04721002 2023-10-18

MEDICI

514 enrolled

Multiple Myeloma, Recurrence

NCT05217082 2023-06-09

A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure

35 enrolled

Multiple Myeloma, Recurrence

NCT05693831 2023-01-23

myCare-102

730 enrolled

Neoplasms, Recurrence

NCT02164955 2022-10-20

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

775 enrolled

Multiple Myeloma, Recurrence

NCT04962529 2022-08-11

Breast Cancer Liquid Biopsy Trial

450 enrolled

Breast

Breast Neoplasms, Neoplasms, Recurrence

NCT05068609 2022-05-05

VOLUME-PRO

509 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT05123950 2021-11-17

A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

304 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT03353545 2021-05-12

POWERFUL

110 enrolled

Multiple Myeloma, Recurrence

NCT02139592 2020-07-13

Brentuximab Vedotin (Recombinant) for IV Infusion - Special Drug Use Surveillance (All-case Surveillance) "Relapsed or Refractory CD30+ Hodgkin's Lymphoma or Anaplastic Large Cell Lymphoma"

292 enrolled 39 charts

Recurrence, Lymphoma, Large-Cell, Anaplastic

NCT02387879 2019-09-26

A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Lenalidomide TR

500 enrolled

Multiple Myeloma, Recurrence

NCT01040312 2019-05-23

An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors

GastrointestinalGynecologicThoracic

321 enrolled

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Ovarian Neoplasms, Recurrence, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT03000335 2019-02-04

Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk

65 enrolled

Burkitt Lymphoma, Recurrence

NCT03772197 2018-12-19

Parallel Comparison of 18 Gene Classifiers and Oncotype DX (Nanostring)

138 enrolled

Breast

Breast Neoplasms, Recurrence

NCT02262273 2017-03-01

OSCA

2,123 enrolled

Gynecologic

Ovarian Neoplasms, Recurrence

NCT02341781 2017-01-26

MCL-004

30 enrolled

Recurrence, Lymphoma, Mantle-Cell

NCT02072967 2016-02-22

Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

97 enrolled

Lymphoma, Non-Hodgkin, Recurrence

NCT02486952 2016-02-22

MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma

154 enrolled 6 charts

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT01020604 2013-04-30

PROTECT-Z

1,376 enrolled

GenitourinaryOther

Obesity, Prostatic Neoplasms, Recurrence

NCT00288275 2012-10-05

Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer

256 enrolled

Gynecologic

Fallopian Tube Neoplasms, Hypersensitivity, Ovarian Neoplasms, Peritoneal Neoplasms, Recurrence

NCT00669422 2012-10-05

ChemoFx® PRO - A Post-Market Data Collection Study

2,756 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Hypersensitivity, Ovarian Neoplasms, Recurrence, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT01271959 2012-10-05

A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study

EndocrineGynecologicOther solid neoplasmSarcomaThoracic

167 enrolled

Adenocarcinoma, Carcinoid Tumor, Mesothelioma, Recurrence, Sarcoma, Uterine Neoplasms

NCT00644020 2008-03-26

Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients